Laura McOlash

807 total citations
15 papers, 661 citations indexed

About

Laura McOlash is a scholar working on Immunology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Laura McOlash has authored 15 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Oncology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Laura McOlash's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Laura McOlash is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Laura McOlash collaborates with scholars based in United States, Switzerland and France. Laura McOlash's co-authors include Bryon D. Johnson, Jill A. Gershan, Michael B. Dwinell, Katie Palen, Qiuhui Yang, Bryan Hunt, Douglas B. Evans, Susan Tsai, Christine Duris and Michael A. James and has published in prestigious journals such as The Journal of Immunology, Cancer Research and The Journal of Infectious Diseases.

In The Last Decade

Laura McOlash

15 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura McOlash United States 13 426 263 156 123 101 15 661
Henrik Jespersen Sweden 15 425 1.0× 310 1.2× 72 0.5× 349 2.8× 89 0.9× 25 787
Morgan A. Giese United States 7 267 0.6× 462 1.8× 84 0.5× 247 2.0× 101 1.0× 13 798
Katie Palen United States 9 456 1.1× 245 0.9× 175 1.1× 185 1.5× 131 1.3× 20 665
Rekha Samuel United States 9 261 0.6× 196 0.7× 114 0.7× 280 2.3× 162 1.6× 9 706
Yunxin Lai China 9 504 1.2× 250 1.0× 175 1.1× 227 1.8× 86 0.9× 10 779
Christian Seitz Germany 11 338 0.8× 205 0.8× 63 0.4× 246 2.0× 43 0.4× 40 663
Margareta P. Correia Portugal 14 302 0.7× 527 2.0× 63 0.4× 273 2.2× 139 1.4× 26 880
Tomáš Brtnický Czechia 8 364 0.9× 485 1.8× 69 0.4× 145 1.2× 49 0.5× 13 688
Haofan Jin China 13 345 0.8× 361 1.4× 43 0.3× 176 1.4× 62 0.6× 25 681
Alexander Biederstädt Germany 5 375 0.9× 402 1.5× 81 0.5× 155 1.3× 39 0.4× 9 604

Countries citing papers authored by Laura McOlash

Since Specialization
Citations

This map shows the geographic impact of Laura McOlash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura McOlash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura McOlash more than expected).

Fields of papers citing papers by Laura McOlash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura McOlash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura McOlash. The network helps show where Laura McOlash may publish in the future.

Co-authorship network of co-authors of Laura McOlash

This figure shows the co-authorship network connecting the top 25 collaborators of Laura McOlash. A scholar is included among the top collaborators of Laura McOlash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura McOlash. Laura McOlash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
McAllister, Donna, Laura McOlash, Gang Cheng, et al.. (2021). Synchronous effects of targeted mitochondrial complex I inhibitors on tumor and immune cells abrogate melanoma progression. iScience. 24(6). 102653–102653. 21 indexed citations
2.
McAllister, Donna, Laura McOlash, Matthew J. Riese, et al.. (2021). STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer. Cellular and Molecular Gastroenterology and Hepatology. 12(1). 41–58. 43 indexed citations
3.
Tsai, Susan, Laura McOlash, Katie Palen, et al.. (2018). Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models. BMC Cancer. 18(1). 335–335. 318 indexed citations
4.
Newman, Debra K., Guoping Fu, Laura McOlash, et al.. (2018). Frontline Science: PECAM-1 (CD31) expression in naïve and memory, but not acutely activated, CD8+ T cells. Journal of Leukocyte Biology. 104(5). 883–893. 16 indexed citations
5.
Tsai, Susan, Laura McOlash, Shuang Jia, et al.. (2018). A Serum-Induced Transcriptome and Serum Cytokine Signature Obtained at Diagnosis Correlates with the Development of Early Pancreatic Ductal Adenocarcinoma Metastasis. Cancer Epidemiology Biomarkers & Prevention. 28(4). 680–689. 2 indexed citations
6.
Jing, Weiqing, Jill A. Gershan, Sandra Holzhauer, et al.. (2017). T Cells Deficient in Diacylglycerol Kinase ζ Are Resistant to PD-1 Inhibition and Help Create Persistent Host Immunity to Leukemia. Cancer Research. 77(20). 5676–5686. 17 indexed citations
7.
Jing, Weiqing, Jill A. Gershan, Grace C. Blitzer, et al.. (2017). Adoptive cell therapy using PD-1+ myeloma-reactive T cells eliminates established myeloma in mice. Journal for ImmunoTherapy of Cancer. 5(1). 51–51. 29 indexed citations
8.
Jing, Weiqing, Jill A. Gershan, James J. Weber, et al.. (2015). Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma. Journal for ImmunoTherapy of Cancer. 3(1). 2–2. 98 indexed citations
9.
Rosenblum, Michael D., et al.. (2005). Characterization of CD200-Receptor Expression in the Murine Epidermis. Journal of Investigative Dermatology. 125(6). 1130–1138. 23 indexed citations
11.
Margolis, David A., J. Casper, Annette D. Segura, et al.. (2000). Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire. Biology of Blood and Marrow Transplantation. 6(4). 408–415. 20 indexed citations
12.
Margolis, David M., et al.. (1997). Concurrent or sequential delta and beta TCR gene rearrangement during thymocyte development: individual thymi follow distinct pathways. The Journal of Immunology. 159(2). 529–533. 10 indexed citations
13.
Truitt, Robert L., et al.. (1992). Immunological Evaluation of Pediatric Cancer Patients Receiving Recombinant Interleukin-2 in a Phase I Trial. Journal of Immunotherapy. 11(4). 274–285. 14 indexed citations
14.
Traul, Donald L., et al.. (1991). Evaluation of Merocyanine 540-Sensitized Photoirradiation as a Method for Purging Malarially Infected Red Cells from Blood. The Journal of Infectious Diseases. 163(6). 1312–1317. 14 indexed citations
15.
McOlash, Laura, et al.. (1991). Plasma membrane properties regulating the sensitivity of leukemia, lymphoma, and solid tumor cells to merocyanine 540-sensitized photoirradiation.. PubMed. 19(8). 785–8. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026